New insider activity at Delcath Systems ( (DCTH) ) has taken place on November 25, 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Director John Richard Sylvester has made a significant investment in Delcath Systems by purchasing 4,386 shares of the company’s stock. This transaction is valued at $38,991, indicating a strong vote of confidence in the company’s future prospects.
Recent Updates on DCTH stock
In the last 24 hours, Delcath Systems has announced a share repurchase program worth up to $25 million, reflecting confidence in its financial health and future prospects. The company’s recent earnings call revealed a mixed outlook, with strong revenue growth from HEPZATO sales and promising CHOPIN trial results, but challenges such as reduced revenue per kit due to 340B pricing and increased operating expenses impacting profitability. Analysts have maintained a neutral stance on the stock, citing strong financial performance and clinical trial outcomes, but also highlighting bearish technical indicators and a high P/E ratio suggesting overvaluation. The company’s strategic expansion of treatment sites and robust cash position provide a solid foundation for future growth, despite competition and seasonal impacts affecting short-term performance.
Spark’s Take on DCTH Stock
According to Spark, TipRanks’ AI Analyst, DCTH is a Neutral.
Delcath Systems’ overall score reflects strong financial performance and promising earnings call highlights, tempered by weak technical indicators and high valuation concerns. The company’s financial improvements and strategic advancements are offset by bearish market trends and valuation risks.
To see Spark’s full report on DCTH stock, click here.
More about Delcath Systems
YTD Price Performance: -26.80%
Average Trading Volume: 872,245
Technical Sentiment Signal: Sell
Current Market Cap: $325.9M